Q32 Bio develops experimental antibody treatments for alopecia areata and other autoimmune and inflammatory diseases. It last closed at $8.34 on Nov 20, down 1.65% on the day. The next earnings report for QTTB is expected around Tue, Mar 9, 2027. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months QTTB insiders bought $30.0M of stock on the open market and sold $505K, according to SEC Form 4 filings.
AI Auto Pilots
Is QTTB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold QTTB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on QTTBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
QTTB · as of the Nov 20 close · updated each morning
Turning down
The stock is 6% below its 20 day and 7% below its 50 day average. It is 15% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the swing low (Nov 5) at $8.22, and the nearest resistance the Pivot at $8.38.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityLow, 6.7%/day
Key levels
$23.5752 week high+182.6%
$11.90100 day average+42.7%
$9.60200 day average+15.1%
$9.01Swing high (Oct 22)+8.0%
$8.9350 day average+7.1%
$8.8120 day average+5.6%
$8.55Pivot R1+2.5%
$8.38Pivot+0.5%
$8.34Last close
$8.22Swing low (Nov 5)−1.4%
$8.18Pivot S1−1.9%
$1.9152 week low−77.1%
Indicators
RSI (14)
40.92
Middle of its range
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
23.2
Middle of its range
Neutral
ADX (14)
17.5
No clear trend
Williams %R
-83.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-121.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.8%
Change over 10 sessions
Bearish
ATR (14)
$0.56
Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 23.3%/day
Key levels
$23.5752 week high+182.6%
$11.90100 day average+42.7%
$9.60200 day average+15.1%
$9.01Swing high (Oct 22)+8.0%
$8.9350 day average+7.1%
$8.8120 day average+5.6%
$8.55Pivot R1+2.5%
$8.38Pivot+0.5%
$8.34Last close
$8.22Swing low (Nov 5)−1.4%
$8.18Pivot S1−1.9%
$1.9152 week low−77.1%
Indicators
RSI (14)
43.24
Middle of its range
Neutral
MACD
-0.33
Below its signal line
Bearish
Stochastic
15.3
Near the bottom of its range
Oversold
ADX (14)
31.4
Trending up
Williams %R
-89.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-74.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−24.9%
Change over 10 sessions
Bearish
ATR (14)
$1.94
Typical daily range, 23.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for QTTB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how QTTB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow QTTB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for QTTBHow many large options trades hit QTTB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in QTTB in the last 90 days.
From SEC Form 4 filings by QTTB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether QTTB is in one of them and how their past QTTB trades turned out.
Q32 Bio is a biotechnology company in Waltham, Massachusetts, that develops experimental biologic medicines for patients with alopecia areata, a condition that causes hair loss, and other autoimmune and inflammatory diseases. Its lead candidate, bempikibart, is an antibody designed to block two immune signals and is being tested in clinical trials. The company also holds a tissue-targeted complement inhibitor platform, which it is evaluating for strategic options.